SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (636)1/25/2001 3:50:07 PM
From: tuck  Read Replies (1) | Respond to of 3044
 
Rick,

>>As a result of such vision, there are young senior scientists who, despite having arrived late, are sporting options worth a bundle. MLNM is going to do everything in their power to bring the Microsoft model of motivation to biotech, and they're batting 100% thus far.<<

Batting more like .950 now, as Structural Genomix, a private San Diego outfit, recently hired Janice Culpepper away. Story at GenomeWeb.com.

Cheers, Tuck



To: scaram(o)uche who wrote (636)1/25/2001 7:00:07 PM
From: nigel bates  Respond to of 3044
 
...one of the top three research organizations, worldwide

Do you happen to remember the other two (serious question) ?

nig


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News